Veeva Systems Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
12.1%projected annual EPS growth
Analyst Coverage
28analysts covering
FY Revenue (est.)
$3.6Bnext fiscal year
FY EPS (est.)
$9.06next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly total revenue year-over-year growth (%) Quarterly18.0%
Quarterly subscription revenue year-over-year growth (%) Quarterly16.0%
Top-20 biopharma companies committed globally to Vault CRM Quarterly12.0
Watch Items
- Fiscal 2027 third-quarter revenue versus management guidanceAction: Reassess near-term demand, implementation timing, and the base-case price target if revenue falls below management's guidance range.
- Commercial progress of the Veeva Falcon agentic platformAction: Review implementation delays, customer conversion evidence, and whether anticipated AI-related growth should remain in the valuation thesis.
Research as of 29 Aug 2026